Publicaciones en colaboración con investigadores/as de Lebanese University (10)

2023

  1. Characterization of Leishmania Parasites Isolated from Naturally Infected Mammals

    Animals, Vol. 13, Núm. 13

  2. Mixed micelles and gels of a hydrophilic poloxamine (Tetronic 1307) and miltefosine: Structural characterization by small-angle neutron scattering and in vitro evaluation for the treatment of leishmaniasis

    Journal of Molecular Liquids, Vol. 379

2022

  1. Correction to: A rapid and low‑cost protocol for the detection of B.1.1.7 lineage of SARS‑CoV‑2 by using SYBR Green‑based RT‑qPCR (Molecular Biology Reports, (2021), 48, 11, (7243-7249), 10.1007/s11033-021-06717-y)

    Molecular Biology Reports

  2. Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis

    Pharmaceutics, Vol. 14, Núm. 11

2021

  1. A rapid and low-cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-based RT-qPCR

    Molecular Biology Reports, Vol. 48, Núm. 11, pp. 7243-7249

  2. Activity of anti-microbial peptides (Amps) against leishmania and other parasites: An overview

    Biomolecules, Vol. 11, Núm. 7

  3. An antibiotic potentiator retains its activity after being immobilized on silicone and prevents growth of multidrug-resistant Pseudomonas aeruginosa biofilms

    Materials Science and Engineering C, Vol. 121

2020

  1. A synthetic peptide sensitizes multi-drug resistant Pseudomonas aeruginosa to antibiotics for more than two hours and permeabilizes its envelope for twenty hours

    Journal of Biomedical Science, Vol. 27, Núm. 1

2019

  1. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains

    Scientific Reports, Vol. 9, Núm. 1

  2. AMPs as anti-biofilm agents for human therapy and prophylaxis

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 257-279